Identifying Risk Factors for Cardiovascular Events Among Active-Duty Service Members and Veterans Prescribed Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

References

• Ugurlucan M, M Caglar I, N Turhan Caglar F, et al. Aspirin: from a Historical Perspective. Recent Patents Cardiovascular Drug Discovery. 2012;7:71–76. doi:10.2174/157489012799362377
   PubMedGoogle Scholar
• Sun SX, Lee KY, Bertram CT, et al. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization. Curr Med Res Opin. 2007;23(8):1859–1866. doi:10.1185/030079907X210561
   PubMed Web of Science ®Google Scholar
• Conaghan P. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int. 2012;32:1491–1502. doi:10.1007/s00296-011-2263-6
   PubMed Web of Science ®Google Scholar
• Bhala N, Emberson J, Merhi A, et al.; Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomized trials. Lancet. 2013;382(9894):769–779. doi:10.1016/s0140-6736(13)60900-9
   PubMed Web of Science ®Google Scholar
• Yuan YH, Wang C, Yuan Y, et al. Meta-analysis: incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo-controlled NSAID trials. Aliment Pharmacol Ther. 2009;30:197–209. doi:10.1111/j.1365-2036.2009.04038.x
   PubMed Web of Science ®Google Scholar
• Ray W, Varas-Lorenzo C, Chung C, et al. Cardiovascular Risks of Nonsteroidal Anti-inflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease. Cir Cardiovasc Qual Outcomes. 2009;2:155–163. doi:10.1161/CIRCOUTCOMES.108.805689
   PubMed Web of Science ®Google Scholar
• Ho KY, Cardosa M, Chaiamnuay S, et al. Practice Advisory on the Appropriate Use of NSAIDs in Primary Care. J Pain Res. 2020;13:1925–1939. doi:10.2147/JPR.S247781
   PubMed Web of Science ®Google Scholar
• Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086. doi:10.1136/bmj.c7086
   PubMed Web of Science ®Google Scholar
• Kearney P, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials. BMJ. 2006;332:1302–1305. doi:10.1136/bmj.332.7553.1302
   PubMed Web of Science ®Google Scholar
• Gunter B, Butler K, Wallace R, et al. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis. J Clin Pharm Ther. 2017;42:27–38. doi:10.1111/jcpt.12484
   PubMed Web of Science ®Google Scholar
• Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ. 2017:357:j1909. doi:10.1136/bmj.j1909
   PubMedGoogle Scholar
• Martin Arias L, Gonazalez A, Fadrique R, et al. Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: a Meta-analysis of Observational Studies. J Clin Pharmacol. 2019;59(1):55–73. doi:10.1002/jcph.1302
   PubMed Web of Science ®Google Scholar
• Garcia Rodgriguez L, Tacconelli S, Patrignani P. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. J Am Coll Cardiol. 2008;52(20):1628–1636. doi:10.1016/j.jacc.2008.08.041
   PubMed Web of Science ®Google Scholar
• Benjamin E, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: a Report From the American Heart Association. Circulation. 2019;139(10):e56–e528. doi:10.1161/CIR.0000000000000659
   PubMed Web of Science ®Google Scholar
• D’Agostino R, Vasan R, Pencina M, et al. General Cardiovascular Risk Profile for Use in Primary Care: the Framingham Heart Study. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–239. doi:10.1016/j.jacc.2013.05.019
   PubMed Web of Science ®Google Scholar
• Page RL, O’Bryant CL, Cheng D, et al. Drugs That May Cause or Exacerbate Heart Failure: a Scientific Statement From the American Heart Association. Circulation. 2016;134(6):e32–69. doi:10.1161/CIR.0000000000000426
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–1324. doi:10.1161/HYP.0000000000000066
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-00007
   PubMed Web of Science ®Google Scholar
• V.A./DoD Clinical Practice Guideline for the Non-Surgical Management of Hip & Knee Osteoarthritis. Available from: https://www.healthquality.va.gov/guidelines/CD/OA/VADoDOACPG.pdf. Accessed August 20, 2023.
   Google Scholar
• Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, Hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27:1578–1589. doi:10.1016/j.joca.2019.06.011
   PubMed Web of Science ®Google Scholar
• Kolasinski SL, Neogi T, Hochberg M, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res. 2020;72(2):149–162. doi:10.1002/acr.24131
   PubMed Web of Science ®Google Scholar
• VA/DoD Clinical Practice Guideline for the Diagnosis and Treatment of Low Back Pain. Available from: https://www.healthquality.va.gov/guidelines/pain/lbp/. Accessed August 20, 2023.
   Google Scholar
• Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514–530. doi:10.7326/M16-2367
   PubMed Web of Science ®Google Scholar
• Stochkendahl MJ, Kjaer P, Hartvigsen J, et al. National clinical guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018;27(1):60–75. doi:10.1007/s00586-017-5099-2
   PubMed Web of Science ®Google Scholar
• Traeger AC, Buchbinder R, Elshaug A, et al. Care for low back pain: can health systems deliver? Bull World Health Organ. 2019;97:423–433. doi:10.2471/BLT.18.226050
   PubMed Web of Science ®Google Scholar
• FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020;72(6):744–760. doi:10.1002/acr.24180
   PubMed Web of Science ®Google Scholar
• Becker CM, Bokor A, Hekinheimo O, et al. ESHRE guideline: endometriosis. Human Reproduction Open. 2022;2022(2):1–26. doi:10.1093/hropen/hoac009
   Google Scholar
• Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol. 2019;71(1):5–32. doi:10.1002/art.40726
   PubMed Web of Science ®Google Scholar
• VA/DoD Clinical Practice Guideline Use of Opioids in the Management of Chronic Pain. Available from: https://www.healthquality.va.gov/guidelines/pain/cot/. Accessed August 20, 2023.
   Google Scholar
• Dowell D, Ragan KR, Jones CM, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain – United States, 2022. MMWR Recomm RepI. 2022;71(No. RR–3):1–95. doi:10.15585/mmwr.rr7103a1
   PubMed Web of Science ®Google Scholar
• DuVall SL, Matheny ME, Ibragimov IR, et al. A Tale of Two Databases: the DoD and V.A.VA Infrastructure for Clinical Intelligence (DaVINCI). Stud Health Technol Inform. 2019;264:1660–1661. doi:10.3233/SHTI190584
   PubMedGoogle Scholar
• Varas-Lorenzo C, Riera-Guardia N, Calingaert B, et al. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2011;20:1225–1236. doi:10.1002/pds.2227
   PubMed Web of Science ®Google Scholar
• Wang H, Bail J, He B, et al. Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observational studies. Sci Rep. 2016;22(6):39672. doi:10.1038/srep39672
   Google Scholar
• Helin-Salmivaara A, Virtanen A, Vesalainen R, et al. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J. 2006;27(14):1657–1663. doi:10.1093/eurheartj/ehl053
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Srivali N, Thongprayoon C. Nonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: a Systematic Review and Meta-analysis of Observational Studies. Clin Cardiol. 2016;39(2):111–118. doi:10.1002/clc.22502
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928–935. doi:10.1161/CIRCULATIONAHA.106.672402
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int j Surg. 2014;12(12):1495–1499. doi:10.1016/j.ijsu.2014.07.013
   PubMed Web of Science ®Google Scholar
• Rodgers J, Jones J, Bolleddu S, et al. Cardiovascular Risks Associated with Gender and Aging. Int J Med. 2019;6(2):19. doi:10.3390/jcdd6020019
   Google Scholar
• Yazdanyar A, Newman A. The Burden of Cardiovascular Disease in the Elderly: morbidity, Mortality, and Costs. Clin Geriatr Med. 2009;24(4):563–577. doi:10.1016/j.cger.2009.07.007
   Google Scholar
• Nissen S, Yeomans N, Solomon D, et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. New Eng J Med. 2017;376(14):1390. doi:10.1056/NEJMoa1611593
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Matteson E, Thongprayoon C. Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: a Systematic Review and Meta-Analysis of Observational Studies. Stroke. 2016;47:356–364. doi:10.1161/STROKEAHA.115.011678
   PubMed Web of Science ®Google Scholar